Cargando…
Hybrid Nanomaterials for Cancer Immunotherapy
Nano‐immunotherapy has been recognized as a highly promising strategy for cancer treatment in recent decades, which combines nanotechnology and immunotherapy to combat against tumors. Hybrid nanomaterials consisting of at least two constituents with distinct compositions and properties, usually orga...
Autores principales: | Li, Jianing, Lu, Wanyue, Yang, Yannan, Xiang, Ruiqing, Ling, Yun, Yu, Chengzhong, Zhou, Yaming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9951325/ https://www.ncbi.nlm.nih.gov/pubmed/36567305 http://dx.doi.org/10.1002/advs.202204932 |
Ejemplares similares
-
Harnessing bioactive nanomaterials in modulating tumor glycolysis-associated metabolism
por: Gu, Zhengying, et al.
Publicado: (2022) -
Nanomaterials for modulating innate immune cells in cancer immunotherapy
por: Le, Quoc-Viet, et al.
Publicado: (2019) -
Nanomaterials: small particles show huge possibilities for cancer immunotherapy
por: Chen, Ziyin, et al.
Publicado: (2022) -
Mesoporous silica/organosilica nanoparticles for cancer immunotherapy
por: Theivendran, Shevanuja, et al.
Publicado: (2023) -
Symphony of nanomaterials and immunotherapy based on the cancer–immunity cycle
por: Li, Qianqian, et al.
Publicado: (2022)